MyWealthGrowth.com logo
HomeMutual Funds

Nippon India Pharma Fund

Nippon India Pharma Fund

Regular PlanGrowth Option

Fund Performance

Lumpsum

SIP

20.81

as on 31 Jan 2023

3 Years

Investment of ₹ 10,000 in this fund 3 Years back would be ₹ 17,642 today.

Invest Now

NAV Performance

Nippon India Pharma Fund performance graph for last 3 years
Performance of Nippon India Pharma Fund for last 3 Years

Fund Information

  • ₹ 275.501

    as on 31 Jan 2023
  • Regular - Growth

  • -

  • ₹ 5,000

  • ₹ 5,224 Cr.

    as on 31 Dec 2021
  • 2%

  • 02 Jan 2013

  • Equity - Sectoral/Thematic

  • S&P BSE Healthcare TRI

  • Nippon India Mutual Fund

    Show All Funds
  • Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges.

Highlights of this fund

Nippon India Pharma Fund is an Open-ended Equity Fund. The fund belongs to Sectoral/Thematic category, where the investment is done in predominantly in stocks that are listed on Stock Exchanges like the Bombay Stock Exchange (BSE) or the National Stock Exchange (NSE) in India as well as Global stock exchanges like the Dow Jones, London Stock Exchange or LSE etc. This fund was started on 02 Jan 2013. This fund is offered by one of the top AMC (Assets Management Company) Nippon India Mutual Fund. You can also view here all other Equity funds offered by Nippon India Mutual Fund.

Latest NAV of the fund is ₹ 275.501 as on 31 Jan 2023.

This fund has 10 years of track record. Since 30 Nov 2021 expense ratio of this fund is 2%. Ideally you shoulds compare this fund with the benchmark S&P BSE Healthcare TRI.

You can invest in this fund in SIP with the minimum investment of ₹ 100. Lumpsum invest is offered with minimum investment of ₹ 5,000.

Fund Objective

To generate consistent returns by investing in equity,equity related of fixed income securities of Pharma and other associated companies.

List of Fund Managers of Nippon India Pharma Fund

  • About Sailesh Raj Bhan

    Picture of Sailesh Raj BhanMr. Sailesh Raj Bhan has over 24 years of experience in Indian Equity Markets with over 15 years at Reliance Nippon Life Asset Management Limited in Fund Management. He manages the flagship diversified equity schemes like Reliance Multi Cap Fund (previously Reliance Equity Opportunities Fund) - a strategy with assets of over Rs10,000cr ($1.5bn) since its inception in March 2005 and Reliance Large Cap Fund (previously Reliance Top200 Fund) – with assets of over Rs13000cr (over $1.8bn) since its inception 2007. Sailesh also manages the Largest Pharma Sector Fund in India since its inception 15 years back in May 2004, in addition to managing Reliance Consumption Fund – a broad based Consumption Thematic product since 2004. He also advises on international mandates for some strategies for the last 5 years.

Riskometer : Risk associated with this fund

Investors understand that their principal will be at High Risk

Fund Return Comparison

Fund Name 1 Month 3 Months 6 Months 1 Year 2 Years 3 Years 5 Years 10 Years 1 Year 2 Years 3 Years 5 Years 10 Years
Category Best 7.75% 26.56% 19.02% 19.38% 39.81% 39.16% 21.52% 20.56% 25.44% 26.37% 39.71% 30.09% 20.52%
Category Average -1.61% -1.38% 4.47% 2.69% 17.54% 16.80% 9.46% 13.21% 6.08% 7.73% 17.58% 15.02% 13.34%
Nippon India Pharma Fund -2.51%₹ 9,748 -4.93%₹ 9,507 0.24%₹ 10,023 -3.83%₹ 9,616 -3.19%₹ 11,791 6.32%₹ 11,306 -2.71%₹ 23,326 20.81%₹ 17,642 7.90%₹ 40,571 13.92%₹ 19,197 14.16%₹ 85,599 15.21%₹ 41,243 13.06%₹ 2,37,236
ICICI Prudential Commodities Fund -2.30%₹ 9,769 6.26%₹ 10,625 14.26%₹ 11,426 12.23%₹ 11,223 17.41%₹ 13,109 39.16%₹ 19,400 18.07%₹ 28,675 39.16%₹ 26,971 38.72%₹ 62,100 - - - -
Quant Infrastructure Fund -4.86%₹ 9,513 -3.02%₹ 9,698 6.67%₹ 10,666 6.25%₹ 10,625 7.91%₹ 12,510 39.81%₹ 19,581 19.49%₹ 29,056 36.96%₹ 25,715 39.71%₹ 62,896 18.42%₹ 23,303 30.09%₹ 1,25,847 16.66%₹ 46,715 20.52%₹ 3,54,544
Quant Consumption Fund -4.64%₹ 9,536 -2.81%₹ 9,719 8.30%₹ 10,829 5.57%₹ 10,557 8.32%₹ 12,536 30.55%₹ 17,068 14.09%₹ 27,620 34.66%₹ 24,435 30.61%₹ 55,842 16.98%₹ 21,913 25.67%₹ 1,13,286 18.43%₹ 54,324 20.48%₹ 3,53,803
ICICI Prudential Technology Fund 2.26%₹ 10,225 1.06%₹ 10,105 1.88%₹ 10,188 -13.72%₹ 8,627 -4.09%₹ 11,731 17.11%₹ 13,726 1.26%₹ 24,317 30.83%₹ 22,407 22.00%₹ 49,670 21.52%₹ 26,513 23.20%₹ 1,06,742 20.56%₹ 64,940 20.06%₹ 3,45,806
SBI Technology Opportunities Fund 3.66%₹ 10,365 3.78%₹ 10,377 6.46%₹ 10,646 -3.02%₹ 9,698 7.19%₹ 12,464 19.76%₹ 14,356 7.96%₹ 26,022 27.60%₹ 20,790 22.32%₹ 49,888 20.62%₹ 25,545 22.45%₹ 1,04,819 18.94%₹ 56,698 18.84%₹ 3,23,728

Portfolio Holdings

Portfolio holdings pattern of Nippon India Pharma Fund as on 01 Feb 2023 are listed below:

  • Equity Holdings:

    99.12%
  • Debt Holdings:

    0.00%
  • Others Holdings:

    0.88%

Top Sector Holdings of Nippon India Pharma Fund

Name of SectorHolding PercentageHolding Values in Crore
Pharmaceuticals 76.57% ₹ 4,131.98 Cr.
Hospital 16.57% ₹ 894.34 Cr.
Healthcare service providers 5.47% ₹ 295.34 Cr.
Medical equipment & supplies 0.51% ₹ 27.79 Cr.
Others .88% -

Top Stock Holdings of Nippon India Pharma Fund

Name of StocksHolding PercentageHolding Values in Crore
Sun Pharmaceutical Industries Ltd. 11.91% ₹ 642.82 Cr.
Dr. Reddys Laboratories Ltd. 9.55% ₹ 515.24 Cr.
Cipla Ltd. 8.75% ₹ 472.05 Cr.
Aurobindo Pharma Ltd. 7.62% ₹ 411.24 Cr.
Lupin Ltd. 7.40% ₹ 399.32 Cr.
Others 54.77% -

Other Holdings

Holding TypeHolding Percentage
TREPS 1.17%
Margin 0.17%
Net Receivables -0.46%